abrdn Healthcare Investors (HQH) director Alan R. Goodson sold 242 shares of Common Stock at $19.3181 per share on October 6, 2026. His reported direct holdings following the sale were zero shares. The transaction is described as a sale in the open market or a private transaction. No Rule 10b5-1 plan is reported.
abrdn Healthcare Investors director Chris LaVictoire Mahai purchased 501 shares of Common Stock at $20.9600 per share on July 16, 2026. After this open-market transaction, the director directly owns 501.0000 shares of HQH. The filing indicates the trade was not made under a Rule 10b5-1 plan.
abrdn Healthcare Investors filed an initial insider ownership report for Mahai Chris LaVictoire. The filing identifies LaVictoire as a director of the fund but does not list any specific transactions or holdings. This is a baseline disclosure establishing their status as a reporting insider.
abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund and abrdn World Healthcare Fund are asking shareholders to elect trustees at joint annual meetings on May 27, 2026. Each fund will vote on two trustee nominees whose new staggered terms would run until the 2029 annual meeting.
Shareholders of record as of April 1, 2026 can vote by mail, phone, internet or in person in Philadelphia. The boards, which are majority independent and chaired by independent trustee Todd Reit, recommend voting “FOR” all nominees. KPMG LLP remains the independent registered public accounting firm, and detailed information on trustee backgrounds, fund ownership, audit fees and trustee compensation is provided to support voting decisions.
An officer of abrdn Healthcare Investors, serving as a vice president, filed an initial insider ownership report for HQH as of 12/09/2025. The filing states that no securities of abrdn Healthcare Investors are beneficially owned by this reporting person. The report is filed by a single reporting person and is accompanied by a power of attorney authorizing the signatory.